1Menger MD, Thierjung C, Hammersen F, et al. Dextran vs hydroxyethyl starch in inhibition of postischemic leukocyte adherence in striated muscle. Circ Shock, 1993, 41: 248-255.
2Collis RE, Collins PW, Gutteridge CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation:an in vitro study. Intensive Care Med, 1994, 20: 37-41.
3Hofbauer R, Moser D, Hornykewyca S, et al. Hydroxyethyl starch reduces the chemotaxis of white cells through endothelial cell monolayers.Transfusion, 1999, 39: 289-294.
4Mielke LL, Entholzner EK, Kling M, et al. Preoperative acute hypervolemic hemodilution with hydroxyethylstarch: an alternative to acute normovolemic hemodilution? Anesth Analg, 1997, 85: 1412-1413.
5Walembe H, Davies KJ, Chai D, et al. Alteration of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Rad Biol Med, 1990, 9: 507-511.
6Lacombe C, Lee A J, Smith WC, et al. Competitive role between fibrinogen and abumin on thixotropy of red cell suspensions. Biorheology,1988, 25: 349-355.
7Hankeln K, Senker R, Beez M, et al. A comparative study of the effectiveness of 5% human albumin and 10% hydroxyethyl starch (HAES-steril) for correcting hemodynamics and O2 transport in surgical interventions. Anesteziol Reanimatol, 1997, 23:23-26.
8Hoffmann JN, Vollmar B, Laschke MW, et al. Hydroxyethyl starch (130kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology, 2002, 97:460-470.
